Catalyst Pharmaceuticals (NasdaqCM:CPRX) recently appointed Dr. William T. Andrews as Chief Medical Officer, a move that underscores the company's focus on advancing its leadership in rare disease ...

It allowed us to be confident,” Valley coach Endy Morales said of the four-run surge. “We had lost to them already this week; ...

Venture capital firm General Catalyst made waves in October 2023 when it announced the launch of HATCo to provide advisory ...

Catalyst Pharmaceuticals appoints Dr. William Andrews as Chief Medical Officer, succeeding Dr. Gary Ingenito. Quiver AI Summary. Catalyst Pharmaceuticals has announced the appointment of Dr ...

Catalyst Fitness owners Amy and Joe Bueme with Apex MD Chief Medical Officer Dr. Jim Bowen and Apex MD Founder and CEO Randall Hunt Catalys ...

Digital healthcare company Sword Health said on Tuesday it has secured a valuation of $4 billion after raising $40 million in ...

The perennial problem with innovation is one of who will be in control to ensure that all of humankind will benefit fairly.

Catalyst Pharmaceuticals (NasdaqCM:CPRX) recently announced the appointment of William T. Andrews, MD, as Chief Medical Officer, a move that coincides with a 13% rise in the company's share price ...

In a landmark academic initiative, the students of Government Medical College, Ernakulam are proud to launch Catalyst 2025 – All India NEET PG Mock Test, scheduled for June 22, 2025. Designed to ...

Edge AI represents the convergence of AI and edge computing, enabling AI algorithms to run directly on local devices rather ...

Artificial intelligence and software company Commure received $200 million in growth financing from General Catalyst’s ...

Catalyst Pharmaceuticals has provided a revenue guidance range for 2025 of $545-$565 million, with significant contributions expected from its products Firdapse, Agamry, and Fycompa.